Trial Details
COMPLETEDBasic Information
| Clinical ID | c2918 |
|---|---|
| Identifier | NCT02782663 |
| Trial Title | A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease (CD) |
| Interventions | DRUG: ABT-494 |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | La Jolla |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2016-05-18 |
|---|---|
| Primary Completion Date | 2025-07-18 |
| Completion Date | 2025-07-18 |